Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HIVIS03 HIV vaccine trial
PACTR2009040001075080Phase 2Unknown
- Sponsor
- Swedish Institute for Infectious Disease Control
- Start
- Feb 2007
- Modality
- Prophylactic Vaccines → Vaccines & Immunotherapeutics, DNA Vaccines → Plasmid DNA → DNA Therapeutics → Nucleic Acid Therapeutics
- Countries
- 1
01
Overview
Phase 2 trial of EP-1090 and saline in human immunodeficiency virus infection (HIV) (3 arms), sponsored by Swedish Institute for Infectious Disease Control. Status: unknown.
02
Drugs
EP-1090saline
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on PACTR2009040001075080.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR2009040001075080.